Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors
<p>Abstract</p> <p>Background</p> <p>Psychotic depression is a clinical subtype of major depressive disorder. A number of clinical studies have demonstrated the efficacy of the combination of an antidepressant (for example, a tricyclic antidepressant or selective serotonin reuptake inhibitor (SSRI))...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2009-12-01
|
| Серія: | Annals of General Psychiatry |
| Онлайн доступ: | http://www.annals-general-psychiatry.com/content/8/1/26 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|